Hamdard Labs to conduct clinical trials of immunity booster medicines against COVID-19

The company has submitted the proposal for required permission from the concerned authorities and the clinical trial will be conducted at Hamdard Institute of Medical Sciences and Research, New Delhi, Hamdard Laboratories said in a statement.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/36H2Nq1
via IFTTT